WSO - April 2023 - 463

Kõrv et al.
463
standard " for studying the epidemiology of stroke,14 such
studies reporting the trends in stroke incidence in younger
ages are rare.
The epidemiology of stroke has been repeatedly studied in
Tartu, Estonia. Three comprehensive stroke registries were
created in 1970-1973,15 in 1991-1993,16 and 2001-2003.17
Most recently, in 2013-2017,18 an epidemiological study was
performed in young adults of the same population.
Aims
The aim of this study was to analyze the trends in first-ever
stroke incidence in 15- to 54-year-old residents of Tartu,
Estonia, from 1991 to 2017 by comparing data from previous
population-based registries.
Methods
Study population
Tartu is the second-largest town in Estonia and houses the
only University Hospital in the country. All strokes from
South Estonia are hospitalized to the comprehensive
stroke center of the Tartu University Hospital. The mean
population of Tartu in 1991 to 1993 (first period) was
110,631
inhabitants,
in
2001-2003
(second
period)
101,122 inhabitants and in 2013-2017 (third period)
97,600 inhabitants.19
Case ascertainment
All previously conducted studies have used prospective
population-based design with multiple overlapping data
sources. The methodology used has been previously published
more extensively elsewhere18,20,21 and is described
in more detail in Supplementary material 1. The design
has been similar throughout all periods using " hot pursuit "
procedures to ascertain cases hospitalized to the
Tartu University Hospital's department of neurology combined
with " cold pursuit " to ensure completeness and
validity.
The first two periods used identical case ascertainment
procedures, with the only difference being the incomplete
availability of imaging techniques in 1991-1993. During
the third study period, we used additional novel digital
solutions for " cold pursuit " of cases: death certificates from
the Estonian Cause of Death Registry and the Estonian
Electronic Health Record (e-Health Record).22
All medical documents of the retrieved cases were
reviewed and verified by the study team.
Stroke was diagnosed based on clinical evaluation
according to the World Health Organization (WHO) definition
criteria23 and was classified into subtypes as AIS,
intracerebral hemorrhage (ICH) or subarachnoid hemorrhage
(SAH).
Statistical analysis
Incidence rates per 100,000 person-years were calculated
using population data from Statistics Estonia for relevant
age- and sex-groups. For the first study period in 1991 to
1993 mean population of Tartu was used, for the second and
third study period the population sizes of Tartu were received
from 2000 and 2011 censuses, respectively.19 Incidence
rates were standardized to the 197624 European standard
population using five-year age groups. Incidence rates
between sexes and between study periods were compared
using rate ratio (RR). Confidence intervals (CIs) to RR were
calculated using Poisson regression. CIs to the standardized
RR have been estimated by the modified F-interval method.
Trends have been calculated and presented as annual percentage
change in incidence rates and are assumed to be
constant between study periods. Comparisons were made
first versus second, second versus third, and first versus
third study period.
The mean age at onset in different study periods was
compared using the Kruskal-Wallis test. Pairwise comparisons
were made with Wilcoxon rank sum tests, and p values
were adjusted for multiple comparisons using the Holm-
Bonferroni method. Variance has been represented using
standard deviation (SD).
Statistical analysis was performed with Stata 14.2
(StataCorp, College Station, TX, USA).
Ethics approval
Ethics approval was obtained from the Research Ethics
Committee of the University of Tartu (281/M-11), the
Estonian Council on Bioethics (1.1-12/619), and the
Estonian Data Protection Inspectorate (2.2.-1/17/46).
Informed consent was obtained from patients included prospectively;
from patients included retrospectively, informed
consent was not required.
Results
There were altogether 259 first-ever strokes in 15- to
54-year-old residents of Tartu during the study period. The
proportion of strokes in females increased through the
study years from 38.3% during the first to 43.6% during the
third period. The mean age at onset decreased during the
study years being 46.6 (SD: 8.3) during the first, 45.1 (SD:
7.8) during the second and 44.3 (SD: 8.5) during the third
period (p = 0.037). There were no changes in the mean age
of first-ever stroke in men; however, in women, the mean
age decreased from 46.9 (SD: 7.3) to 42.6 (SD: 8.9) 1991
through 2017 (p = 0.022).
The overall incidence rates of first-ever stroke decreased
significantly as can be observed from Table 1. The change
happened mostly in men between the first two study periods.
For example, compared to the 1991 to 1993 study
International Journal of Stroke, 18(4)

WSO - April 2023

Table of Contents for the Digital Edition of WSO - April 2023

Contents
WSO - April 2023 - Cover1
WSO - April 2023 - Cover2
WSO - April 2023 - 375
WSO - April 2023 - Contents
WSO - April 2023 - 377
WSO - April 2023 - 378
WSO - April 2023 - 379
WSO - April 2023 - 380
WSO - April 2023 - 381
WSO - April 2023 - 382
WSO - April 2023 - 383
WSO - April 2023 - 384
WSO - April 2023 - 385
WSO - April 2023 - 386
WSO - April 2023 - 387
WSO - April 2023 - 388
WSO - April 2023 - 389
WSO - April 2023 - 390
WSO - April 2023 - 391
WSO - April 2023 - 392
WSO - April 2023 - 393
WSO - April 2023 - 394
WSO - April 2023 - 395
WSO - April 2023 - 396
WSO - April 2023 - 397
WSO - April 2023 - 398
WSO - April 2023 - 399
WSO - April 2023 - 400
WSO - April 2023 - 401
WSO - April 2023 - 402
WSO - April 2023 - 403
WSO - April 2023 - 404
WSO - April 2023 - 405
WSO - April 2023 - 406
WSO - April 2023 - 407
WSO - April 2023 - 408
WSO - April 2023 - 409
WSO - April 2023 - 410
WSO - April 2023 - 411
WSO - April 2023 - 412
WSO - April 2023 - 413
WSO - April 2023 - 414
WSO - April 2023 - 415
WSO - April 2023 - 416
WSO - April 2023 - 417
WSO - April 2023 - 418
WSO - April 2023 - 419
WSO - April 2023 - 420
WSO - April 2023 - 421
WSO - April 2023 - 422
WSO - April 2023 - 423
WSO - April 2023 - 424
WSO - April 2023 - 425
WSO - April 2023 - 426
WSO - April 2023 - 427
WSO - April 2023 - 428
WSO - April 2023 - 429
WSO - April 2023 - 430
WSO - April 2023 - 431
WSO - April 2023 - 432
WSO - April 2023 - 433
WSO - April 2023 - 434
WSO - April 2023 - 435
WSO - April 2023 - 436
WSO - April 2023 - 437
WSO - April 2023 - 438
WSO - April 2023 - 439
WSO - April 2023 - 440
WSO - April 2023 - 441
WSO - April 2023 - 442
WSO - April 2023 - 443
WSO - April 2023 - 444
WSO - April 2023 - 445
WSO - April 2023 - 446
WSO - April 2023 - 447
WSO - April 2023 - 448
WSO - April 2023 - 449
WSO - April 2023 - 450
WSO - April 2023 - 451
WSO - April 2023 - 452
WSO - April 2023 - 453
WSO - April 2023 - 454
WSO - April 2023 - 455
WSO - April 2023 - 456
WSO - April 2023 - 457
WSO - April 2023 - 458
WSO - April 2023 - 459
WSO - April 2023 - 460
WSO - April 2023 - 461
WSO - April 2023 - 462
WSO - April 2023 - 463
WSO - April 2023 - 464
WSO - April 2023 - 465
WSO - April 2023 - 466
WSO - April 2023 - 467
WSO - April 2023 - 468
WSO - April 2023 - 469
WSO - April 2023 - 470
WSO - April 2023 - 471
WSO - April 2023 - 472
WSO - April 2023 - 473
WSO - April 2023 - 474
WSO - April 2023 - 475
WSO - April 2023 - 476
WSO - April 2023 - 477
WSO - April 2023 - 478
WSO - April 2023 - 479
WSO - April 2023 - 480
WSO - April 2023 - 481
WSO - April 2023 - 482
WSO - April 2023 - 483
WSO - April 2023 - 484
WSO - April 2023 - 485
WSO - April 2023 - 486
WSO - April 2023 - 487
WSO - April 2023 - 488
WSO - April 2023 - 489
WSO - April 2023 - 490
WSO - April 2023 - Cover3
WSO - April 2023 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com